Table 1. Performance Measures and Definitions Included in the Basic Clinical Relevant Mammography Audit of the American College of Radiology.
Performance Measure | Definition |
---|---|
Recall rate | Percentage of screening examinations recommended for additional imaging (BI-RADS category 0) |
Abnormal interpretation rate | Percentage of screening examinations interpreted as positive (BI-RADS categories 0, 4, and 5) |
Recommendation for biopsy or surgical consultation | Number of recommendations for biopsy or surgical consultation (BI-RADS categories 4 and 5) |
Known false-negatives | Diagnosis of cancer within 1 year of a negative mammogram (BI-RADS categories 1 or 2 for screening examination; BI-RADS categories 1, 2, or 3 for diagnostic examination) |
Sensitivity | Probability of detecting a cancer when a cancer exists (true-positive examinations / all examinations with cancer detected within 1 year) |
Specificity | Probability of interpreting an examination as negative when a cancer does not exist (true-negative examinations / all examinations without cancer detected in 1 year) |
PPV1 | Percentage of all positive screening examinations that result in a cancer diagnosis within 1 year |
PPV2 | Percentage of all screening or diagnostic examinations recommended for biopsy or surgical consultation that result in a cancer diagnosis within 1 year |
PPV3 | Percentage of all biopsies done after a positive screening or diagnostic examination that result in a cancer diagnosis within 1 year |
Cancer detection rate | Number of cancers correctly detected per 1,000 screening mammograms |
Minimal cancers | Percentage of all cancers that are invasive and ≤ 1 cm, or ductal carcinoma in situ |
Node-negative cancers | Percentage of all invasive cancers that are node negative |
Note—PPV = positive predictive value.